Search Within

Nicholas D Socci

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (72)
  2. Meeting Abstract (36)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Human Oncology and Pathogenesis Program (110)
  2. GSK Faculty (109)
  3. Department of Pathology and Laboratory Medicine (95)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (80)
  5. Department of Medicine (71)
  6. Sloan Kettering Institute Postdocs (65)

More Groups

People
  1. Agnes Viale (43)
  2. Michael Berger (37)
  3. Nikolaus Schultz (36)
  4. Marc Ladanyi (28)
  5. David Solit (26)
  6. Chris Sander (23)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (6)
  4. 2022 (9)
  5. 2021 (3)
  6. 2020 (13)

More Years

Publications
  1. Nature Communications (13)
  2. Journal of Clinical Oncology (10)
  3. Clinical Cancer Research (9)
  4. Cancer Research (8)
  5. Nature (8)
  6. Cancer Discovery (7)

More Publications

Publishers
  1. Nature Publishing Group (33)
  2. American Association for Cancer Research (26)
  3. American Society of Clinical Oncology (10)
  4. American Society of Hematology (5)
  5. Cell Press (5)
  6. Nature Research (5)

More Publishers

Results (110)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next generation sequencing (NGS): Results from RECORD-3
    Meeting Abstract

    Hsieh, J.; Chen, D.; Wang, P.; Chen, Y. B.; Redzematovic, A.; Marker, M.; Patel, P.; Chevinsky, M.; Bhanot, U.; Pinciroli, P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identifying somatic oncogenic mutations in leukocytes that infiltrate primary breast cancers
    Meeting Abstract

    Comen, E. A.; Kleppe, M.; Wen, Y. H.; Rapaport, F.; Granot, Z.; Socci, N. D.; Viale, A.; You, D.; Benezra, R.; Weigelt, B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
    Journal Article

    Meyer, S.; Keller, M.; Chiu, S.; Koppikar, P.; Guryanova, O.; Rapaport, F.; Xu, K.; Manova, K.; Pankov, D.; O'reilly, R.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Somatic leukemogenic mutations associated with infiltrating white blood cells in breast cancer patients
    Meeting Abstract

    Comen, E. A.; Kleppe, M.; Wen, H.; Weigelt, B.; Bastian, L.; Blum, B.; Rapaport, F. T.; Keller, M.; Socci, N.; Viale, A.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia
    Journal Article

    Shih, A. H.; Jiang, Y.; Meydan, C.; Shank, K.; Pandey, S.; Barreyro, L.; Antony-Debre, I.; Viale, A.; Socci, N.; Sun, Y.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing analysis of angiosarcomas reveals common MAPK pathway alterations and MYC amplifications
    Meeting Abstract

    Murali, R.; Chandramohan, R.; Moller, I.; Berger, M.; Huberman, K.; Viale, A.; Pirun, M.; Socci, N.; Bouvier, N.; Hillen, U.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing analysis of angiosarcomas reveals common MAPK pathway alterations and MYC amplifications
    Meeting Abstract

    Murali, R.; Chandramohan, R.; Moller, I.; Berger, M.; Huberman, K.; Viale, A.; Pirun, M.; Socci, N.; Bouvier, N.; Hillen, U.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • The MSK clinical variants database and e-signout system
    Meeting Abstract

    Syed, A.; Zehir, A.; Shah, R.; Prasad, M.; Liu, Z.; Schultz, N.; Gao, J.; Gabow, A.; Wilson, M.; Socci, N. D.; more...
    Journal of Molecular Diagnostics (2014)

    Fulltext@MSK | Save
  • Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
    Journal Article

    Al-Ahmadie, H.; Iyer, G.; Hohl, M.; Asthana, S.; Inagaki, A.; Schultz, N.; Hanrahan, A. J.; Scott, S. N.; Brannon, A. R.; McDermott, G. C.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • A recurrent point mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
    Meeting Abstract

    Kohsaka, S.; Shukla, N.; Ameur, N.; Lim, D. ; Viale, A.; Socci, N.; Qin, L. X.; Sciot, R.; Bridge, J.; Singer, S.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save